Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements.

Compiled by the New Jersey State Library2019-08-012019-08-01http://hdl.handle.net/10929.1/26498Year: 2016; Chapter: 73Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements.Legislative History